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Outcomes for certain surgical procedures have been
linked with volume: hospitals performing a high num-
ber of procedures demonstrate better outcomes than
do low-volume centers. This study examines the effect
of volume on hepatic and renal transplant outcomes.
Data from the Scientific Registry of Transplant Recip-
ients were analyzed for transplants performed from
1996–2000. Transplant centers were assigned to vol-
ume quartiles (kidney) or terciles (liver). Logistic re-
gression models, adjusted for clinical characteristics
and transplant center clustering, demonstrate the ef-
fect of transplant center volume quantile on 1-year
post-transplant patient mortality (liver) and graft loss
(kidney). The unadjusted rate of renal graft loss within
1 year was significantly lower at high volume centers
(8.6%) compared with very low (9.6%), low (9.9%) and
medium (9.7%) volume centers (p = 0.0014). After ad-
justment, kidney transplant at very low [adjusted odds
ratio (AOR) 1.22; p = 0.043) and low volume (AOR 1.22
p = 0.041) centers was associated with a higher inci-
dence of graft loss when compared with high volume
centers. Unadjusted 1-year mortality rates for liver
transplant were significantly different at high (15.9%)
vs. low (16.9%) or medium (14.7%) volume centers. Af-
ter adjustment, low volume centers were associated
with a significantly higher risk of death (AOR 1.30; p =
0.0036). There is considerable variability in the range of
failure between quantiles after kidney and liver trans-
plant. Transplant outcomes are better at high volume
centers; however, there is no clear minimal threshold
volume.
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Introduction
Over the last two decades, a strong relationship has been
reported between higher volume, defined as the num-
ber of cases of a given procedure performed at a hospi-
tal, and decreased morbidity and mortality following com-
plex surgical procedures (1,2). This effect likely reflects
a combination of better surgical technique, higher qual-
ity perioperative care, and the increase in referral volume
that results from a history of good outcomes. Further-
more, the beneficial effect of volume extends beyond the
early postoperative period; improved long-term outcomes
at high-volume centers have been demonstrated for sur-
gical treatment of pancreatic cancer (3) and pulmonary
resections (4).
Organ transplantation outcomes reflect the influence of
many factors: patient and donor selection, case mix,
timeliness of donor availability, operative technique, and
postoperative medical management and immunosuppres-
sion. While several previous studies have reported that
outcomes at higher volume centers are better follow-
ing pediatric renal (5), cardiac (6), and liver transplanta-
tion (7), others have failed to demonstrate this effect
(8). The present study examines the effect of center vol-
ume on renal and hepatic transplant outcomes using risk-
stratified models of national data for all patients undergo-
ing these two transplant procedures over a recent 5-year
period.
Methods
Data from the Scientific Registry of Transplant Recipients (SRTR) were an-
alyzed for all adult patients who underwent hepatic or renal transplantation
from January 1, 1996 to December 31, 2000. The primary outcome was
death at 1 year (liver) and graft failure including death with a functioning
graft at 1 year (kidney). Models were adjusted for the following covariates:
donor characteristics [age, race, cause of death, gender, expanded criteria
donor status (9) (kidney), living or deceased donor source], recipient charac-
teristics [age, race, gender, previous organ transplant, preoperative hospital-
ization, panel reactive antibody (PRA) level (kidney), use of induction therapy
with antilymphocyte antibodies (kidney), HLA mismatching (kidney), time
on dialysis before transplant (kidney)], elevated creatinine (liver), and cold
ischemia time.
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Total transplant center volume over the study period for the organ of interest
was used to assign each center into a volume quantile. Renal transplant cen-
ters were divided a priori into quartiles consisting of an equivalent number
of transplants (the number of transplant centers varies between quartiles).
Liver transplant centers were assigned to volume terciles. Volume cut-off
points, including the number of quantiles, were selected before outcome
data analysis to avoid bias. The use of terciles rather than quartiles for the
liver model reflects the lower number of such procedures and was chosen
to enhance statistical stability. Patients with at least 1 year of follow up
were included in all subsequent analyses.
Descriptive statistics were compiled and analyzed to assess the relationship
between the available covariates and the outcomes of interest, using the
Student’s t-test and Chi-square analyses, as appropriate. Covariates asso-
ciated with mortality or graft failure (p < 0.10) were included in multivariate
logistic regression analyses. Endpoints for the logistic regression models
were death at 1 year (liver) and graft failure or death at 1 year (kidney).
Volume quantiles were included as a series of categorical variables, with
the highest volume quantile as the reference group. For the logistic regres-
sion models, generalized estimating equations were used to account for
clustering at the transplant center level, assuming a compound symmetry
covariance structure (10). This method accounts for the fact that patients
within a transplant center may be more similar to each other than to patients
in other transplant centers owing to center-specific physician and treatment
practices.
Statistical analyses were conducted using SAS 8.0 (10). The project was
approved by the University of Michigan Medical School Institutional Review
Board.
Table 1: Kidney transplant center characteristics by volume quartile
Volume quartile
Very low Low Medium Large p-value
Number of renal transplants (1996–2000) 15 127 15 084 15 169 15 398
Number of centers 158 51 32 17
Median annual volume per center 20 58 93 167
Unadjusted graft failure rate at 1 year (%) 9.6 9.9 9.7 8.6 0.0014
Table 2: Kidney transplant recipient characteristics by volume quartile
Volume quartile
Very low Low Medium Large p-value
Age 18–34 (%) 23.1 22.4 21.4 21.2 <0.001
Age 35–49 (%) 36.1 38.1 36.5 37.0 <0.001
Age 50–64 (%) 33.4 32.8 33.7 33.7 <0.001
Age > 64 (%) 7.4 6.8 8.4 8.1 <0.001
Female (%) 40.0 41.3 41.0 39.5 0.0056
African-American race (%) 20.7 26.1 25.0 20.5 <0.001
Asian race (%) 4.3 3.0 4.1 4.9 <0.001
PRA 80–100 (%) 6.7 7.5 5.9 6.5 <0.001
Diabetic nephropathy (%) 22.5 21.2 20.1 21.5 <0.001
Hypertension (%) 13.1 16.0 14.7 14.8 <0.001
Tubular/interstitial (%) 6.2 6.1 6.2 5.5 0.0543
Polycystic kidney disease (%) 8.6 8.4 9.6 8.5 0.0009
Vascular disease (%) 5.2 4.6 5.5 4.2 <0.001
Congenital abnormality (%) 1.9 1.6 1.7 1.3 0.0032
Previous kidney transplant (%) 11.2 12.1 12.2 11.8 0.0404
Use of induction therapy (%) 45.3 35.7 32.6 43.4 <0.001
Mean time on dialysis (years) before transplant 3.3 3.5 3.4 3.4 <0.001
Results
Kidney transplant center, donor, and recipient
characteristics
Between 1996 and 2000, 60 778 kidney transplants were
performed at 258 US transplant centers. Transplant cen-
ter volume varied widely (Table 1). The very low-volume
quartile centers performed 1–45 transplants per year (me-
dian 20, n = 15 127). Low-volume quartile centers per-
formed 46–75 transplants per year (median 58, n =
15 084). Medium-volume quartile centers performed 76–
124 transplants annually (median 93, n = 15 169), while
high-volume quartile centers performed 125–278 trans-
plants yearly (median 167, n = 15 398).
Recipient characteristics varied significantly between vol-
ume quartiles (Table 2). Centers in the very low-volume
quartile had a significantly lower proportion of 35–49-year-
old recipients than did centers in the high-volume quartile
(36.1% vs. 37.0%; p < 0.001). Very low-volume centers
also had a lower proportion of patients older than 64 years
when compared with high-volume centers (7.4% vs. 8.1%;
p < 0.001).
Donor characteristics (living and deceased combined) also
varied across volume quartiles (Table 3). Very low-volume
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Table 3: Kidney donor characteristics by volume quartile
Volume quartile
Very low Low Medium Large p-value
Donor < 18 (%) 12.2 11.2 11.3 11.2 <0.001
Donor 18–34 (%) 31.5 30.7 28.1 29.6 <0.001
Donor 35–49 (%) 34.5 35.1 36.3 34.5 <0.001
Donor 50–64 (%) 19.2 19.9 20.9 21.5 <0.001
Donor > 64 (%) 2.6 3.1 3.4 3.1 <0.001
African-American race (%) 9.8 13.1 12.6 10.6 <0.001
Living donor (%) 32.3 36.7 33.9 35.8 <0.001
Expanded criteria donor (%) 9.3 9.4 10.8 10.2 <0.001
Mean cold ischemia time (h) for deceased donors 18.5 20.5 21.4 22.1 <0.001
centers were significantly less likely to use kidneys from
donors who were older than 64 years and were signifi-
cantly more likely to use organs from donors younger than
age 35 years when compared with high-volume centers
(p < 0.001). The percentage of transplants using organs
from living donors also varied significantly across volume
quartiles: 32.3% of transplants involved living donors in
very low-volume centers, 36.7% in low-volume centers,
33.9% in medium-volume centers, and 35.8% in high-
volume centers (p < 0.001). Cold ischemia time increased
with volume. Among deceased donors, the mean cold is-
chemia time was 18.5 h in very low-volume centers and
22.1 h in high-volume centers (p < 0.001).
One-year kidney transplant graft outcomes
The overall 1-year unadjusted kidney graft failure rate was
9.4%, and the rates varied significantly by volume quartile
(Table 1). The unadjusted rate of graft failure was lowest in
the high-volume quartile centers (8.6%) and higher in the
very low (9.6%), low (9.9%), and medium (9.7%) volume
centers (p = 0.0014).
Multivariate logistic regression models of graft failure were
fitted to adjust for the observed differences in donor, recip-
ient, and transplant characteristics across volume quartiles
(Table 4). A significantly higher odds ratio of graft failure at
1 year was found in association with older recipient age,
African-American recipient race, high PRA, diabetes, hyper-
tension, tubular diseases, vascular nephropathy, preopera-
tive intensive care requirements, older donor age, African-
American donor race, longer cold ischemia time, increased
number of HLA mismatches, increased time on dialysis be-
fore transplant, and expanded criteria donor kidney. Sev-
eral factors were found to be associated with significantly
lower odds of 1-year graft failure, including receipt of a liv-
ing donor organ, donor age 18–34 years, recipient Asian
race, and recipient diagnosis of polycystic kidney disease.
In this analysis, transplants at very low-volume centers [ad-
justed odds ratio (AOR) 1.22; p = 0.043], low-volume cen-
ters (AOR 1.22; p = 0.041), and medium-volume centers
(AOR 1.21; p = 0.061) were associated with significantly
increased odds of graft failure at 1 year, when compared
with high-volume centers, adjusted for all other factors.
The 95% confidence intervals for odds of graft failure for
patients at very low-, low-, and medium-volume centers
overlapped each other. Corresponding predicted probabili-
ties of graft failure at 1 year for the average kidney recipient
were 8.7%, 8.7%, 8.7%, and 7.2%, respectively. In sepa-
rate analyses, differences between volume quartiles were
also shown to be significant within the first 30 days af-
ter transplant (Table 5), suggesting that the majority of the
center volume effect is seen within the first post-transplant
month.
While the average risk of graft failure was significantly
higher for transplants performed at very low- and low-
volume quartile centers, all four quartiles had substantial
variability in their estimated within-quartile risk (Figure 1A).
This suggests that the outcome at any given center within
the very low- or low-volume quartile is not necessarily
worse than that at a high-volume center.
Liver transplant center, donor, and recipient
characteristics
Between 1996 and 2000, 19 084 adult liver transplants
were performed in the United States at 111 centers
(Table 6). Median annual liver transplant center volume
varied markedly across the volume terciles. In the low-
est volume tercile, 74 centers performed 6258 transplants
(median annual volume 21 [range 1–37]). In the medium-
volume tercile, 25 centers performed 6270 transplants
(median annual volume 48 [range 39–66]). At the 12 cen-
ters in the high-volume tercile, 6556 transplants were per-
formed (median annual volume 93 [range 66–176]).
Liver transplant recipient characteristics demonstrated sig-
nificant differences across volume terciles (Table 7). Older
patients (>64 years) constituted 10.4% of recipients at
high-volume centers but only 6.0% at low-volume centers
(p < 0.001). Compared with the high-volume tercile, pa-
tients at low-volume tercile centers were less likely to be
Asian (2.9% vs. 4.5% p < 0.001) and more likely to be
African-American (8.2% vs. 6.6% p = 0.0017). Patients at
high-volume tercile centers were significantly more likely
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Table 4: Factors associated with kidney allograft failure at 1 year
Adjusted odds ratio 95% confidence interval p-value
Very low-volume transplant center 1.22 1.01 1.48 0.043
Low-volume transplant center 1.22 1.01 1.48 0.041
Medium-volume transplant center 1.21 0.99 1.49 0.061
High-volume transplant center 1.00 – – Reference
Recipient age 18–34 1.03 0.94 1.12 0.54
Recipient age 35–49 1.00 – – Reference
Recipient age 50–64 1.35 1.26 1.45 <0.001
Recipient age > 64 1.79 1.62 1.97 <0.001
Donor age < 18 0.98 0.87 1.09 0.71
Donor age 18–34 0.85 0.78 0.92 <0.001
Donor age 35–49 1.00 – – Reference
Donor age 50–64 1.27 1.16 1.39 <0.001
Donor age > 64 1.52 1.30 1.78 <0.001
HLA mismatch 1.10 1.08 1.13 <0.001
Donor African-American 1.26 1.15 1.38 <0.001
In hospital ICU 2.36 1.59 3.51 <0.001
Cold ischemia time (per hour) 1.01 1.00 1.01 <0.001
Previous kidney transplant 1.09 0.97 1.22 0.16
Recipient African-American 1.11 1.02 1.20 0.012
Recipient Asian 0.71 0.60 0.84 0.0001
Living donor 0.69 0.63 0.76 <0.001
PRA < 10% 1.00 – – Reference
PRA 10%–80% 1.16 1.08 1.25 <0.001
PRA > 80% 1.48 1.33 1.64 <0.001
Diabetes 1.14 1.05 1.24 0.0021
Hypertension 1.08 0.99 1.19 0.096
Polycystic kidney disease 0.83 0.73 0.93 0.0017
Tubular diseases 1.18 1.04 1.33 0.012
Vascular nephropathy 1.12 0.97 1.29 0.11
Congenital 1.11 0.88 1.39 0.38
Other diagnoses 1.14 1.03 1.25 0.011
Expanded criteria donor 1.33 1.20 1.48 <0.001
Use of induction therapy 1.01 0.95 1.09 0.68
Time on dialysis before transplant (per year) 1.02 1.01 1.03 0.0001
Table 5: Adjusted early (30 days) and conditional (31–365 days) kidney graft loss by center volume quartile
Adjusted odds ratio at 30 days 95% confidence interval p-value
Very low-volume transplant center 1.35 1.07 1.70 0.01
Low-volume transplant center 1.35 1.07 1.72 0.01
Medium-volume transplant center 1.28 0.98 1.67 0.07
High-volume transplant center 1.00 – – Reference
Conditional adjusted odds
ratio at 31-365 days 95% confidence interval p-value
Very low-volume transplant center 1.13 0.91 1.40 0.26
Low-volume transplant center 1.12 0.91 1.39 0.29
Medium-volume transplant center 1.14 0.90 1.43 0.27
High-volume transplant center 1.00 – – Reference
to have a diagnosis of malignancy than those at low-volume
tercile centers (4.6% vs. 2.1%; p < 0.001). Patients at cen-
ters in the high-volume tercile appear to have been sicker
than those at centers in the medium- or low-volume ter-
ciles, as assessed by higher incidences of elevated pre-
transplant serum creatinine (p < 0.001), requirement for
life support (p = 0.0042), and preoperative intensive care
unit requirement (p < 0.001). Finally, a significantly higher
proportion of patients at high-volume centers had under-
gone a previous liver transplant (11.4%) compared with
medium-volume centers (8.8%) and low-volume centers
(7.5%) (p < 0.001).
Donor characteristics also varied across volume terciles
(Table 8). Transplants at high-volume centers utilized or-
gans from a significantly greater proportion of donors older
























Figure 1: (A) Box plot of distribution of adjusted odds ratio
of graft failure or death at 1 year after kidney transplant by
center within volume quartile. (B) Box plot of distribution of
adjusted odds ratio of death at 1 year after liver transplant by center
within volume tercile.
Table 6: Liver transplant center characteristics by volume tercile
Volume tercile
Low Medium High p-value
Number of liver transplants (1996–2000) 6258 6270 6556
Number of centers 74 25 12
Median annual volume per center 21 48 93
Unadjusted death rate at 1 year 16.9 14.7 15.9 0.0032
Table 7: Liver recipient characteristics by volume tercile
Volume tercile
Low Medium High p-value
Age 18–34 (%) 7.5 7.6 7.8 <0.001
Age 35–49 (%) 43.9 42.0 37.7 <0.001
Age 50–64 (%) 42.7 43.2 44.1 <0.001
Age > 64 (%) 6.0 7.2 10.4 <0.001
African-American race (%) 8.2 7.3 6.6 0.0017
Asian race (%) 2.9 2.9 4.5 <0.001
Cholestatic liver disease (%) 13.3 13.6 14.0 0.46
Acute hepatic necrosis (%) 8.2 9.2 6.5 <0.001
Metabolic disease (%) 3.2 3.0 3.1 0.73
Malignancy (%) 2.1 2.5 4.6 <0.001
Creatinine > 2.0 (%) 10.9 11.1 13.7 <0.001
ABO incompatible (%) 1.5 1.5 1.3 0.55
On life support (%) 10.2 9.5 11.3 0.0042
In ICU before transplant (%) 22.2 19.0 23.4 <0.001
Previous liver transplant (%) 7.5 8.8 11.4 <0.001
than age 64 years than did low-volume centers (10.3% vs.
4.7%; p < 0.001) and were associated with longer mean
cold ischemia time than medium-volume centers (8.8 h vs.
8.3 h; p < 0.001). No significant differences were found
in the use of living liver donors across volume terciles
(p = 0.45).
One-year mortality after liver transplant
Unadjusted 1-year post-transplant mortality rates varied
across volume terciles (Table 6). In the high-volume ter-
cile, 1-year mortality was 15.9%. In the medium- and low-
volume terciles, mortality rates were 14.7% and 16.9%, re-
spectively. However, after adjustment for recipient, donor,
and transplant characteristics, liver transplants at low-
volume tercile centers were found to be associated with
30% higher odds of death (AOR 1.30; p = 0.0036) when
compared with high-volume centers (Table 9). Although the
odds ratio for death at medium-volume centers was very
similar to high-volume centers, there was no significant dif-
ference between low- and medium-volume centers. Pre-
dicted probabilities of death at 1-year for the average liver
recipient were 16.5%, 13.7%, and 13.2% for transplants
performed at low-, medium-, and high-volume tercile cen-
ters, respectively. Other factors associated with signifi-
cantly higher odds of 1-year mortality included older recip-
ient age, previous organ transplant, preoperative intensive
care unit admission, requirement for life support, elevated
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Table 8: Liver donor characteristics by volume tercile
Volume tercile
Low Medium High p-value
Age < 18 (%) 15.4 15.2 12.2 <0.001
Age 18–34 (%) 33.5 32.0 28.3 <0.001
Age 35–49 (%) 27.8 26.5 26.9 <0.001
Age 50–64 (%) 18.7 20.1 22.2 <0.001
Age > 64 (%) 4.7 6.2 10.3 <0.001
African-American race (%) 11.3 11.2 11.2 0.97
Living donor (%) 2.4 2.4 2.1 0.45
Mean cold ischemia time (h) 8.6 8.3 8.8 <0.001
Table 9: Factors associated with death at 1 year following liver transplant
Adjusted odds ratio 95% confidence interval p-value
Low-volume transplant center 1.30 1.09 1.56 0.0036
Medium-volume transplant center 1.05 0.84 1.30 0.68
High-volume transplant center 1.00 – – Reference
Recipient age 18–34 0.74 0.62 0.89 0.0018
Recipient age 35–49 1.00 – – Reference
Recipient age 50–64 1.28 1.16 1.42 <0.001
Recipient age > 64 1.88 1.62 2.19 <0.001
In hospital ICU 1.24 1.08 1.42 0.0024
On life support 1.58 1.32 1.90 <0.001
Previous liver transplant 2.50 2.21 2.82 <0.001
Cholestatic liver disease/cirrhosis 0.73 0.65 0.84 <0.001
Acute hepatic necrosis 1.12 0.99 1.27 0.077
Metabolic disease 0.89 0.66 1.20 0.46
Malignancy 1.29 1.09 1.53 0.0032
Serum creatinine > 2.0 1.73 1.54 1.93 <0.001
Living Donor 1.59 1.24 2.05 0.0003
Donor age < 18 0.88 0.76 1.02 0.084
Donor age 18–34 0.83 0.75 0.91 0.0002
Donor age 35–49 1.00 – – Reference
Donor age 50–64 1.26 1.14 1.38 <0.001
Donor age > 64 1.57 1.36 1.81 <0.001
Donor African-American race 1.24 1.07 1.44 0.0038
Donor Asian race 1.29 0.90 1.86 0.17
Donor or other unknown races 1.12 0.80 1.58 0.51
Cold ischemia time (per hour over >8.25 h) 1.02 1.01 1.03 <0.001
pretransplant serum creatinine, diagnosis of acute hepatic
necrosis or malignancy, living donor source, longer cold is-
chemia time, older donor age, and African-American donor
race. Associated with significantly lower 1-year mortality
rates were younger recipient age, diagnosis of cholestatic
liver disease, and younger donor age.
As in the kidney graft outcome analysis, across the three
liver-volume terciles there was substantial overlap in the
distribution of estimates of the odds of mortality after liver
transplant by center (Figure 1B). Thus, even though out-
comes on average were worse at low-volume centers,
the outcomes at some low-volume liver transplant centers
were comparable to, or in some cases better than, those
at some high-volume centers.
Discussion
This study confirms an association between transplant cen-
ter volume and outcomes following kidney and liver trans-
plantation in a modern cohort of recipients. Using an anal-
ysis that included clinical information for risk adjustment,
the odds of kidney transplant graft failure at 1 year were
22% higher (p = 0.043) at very low-volume centers, 22%
higher (p = 0.041) at low-volume centers, and 21% higher
(p = 0.061) at medium-volume centers compared with pro-
cedures carried out at high-volume centers. Patients un-
dergoing liver transplants at low-volume centers had 30%
(p = 0.0036) higher odds of death at 1 year compared
with those who received their allografts at high-volume
centers.
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These results are consistent with those of Edwards et al.
(7) who analyzed liver transplant outcomes, and Schurman
et al. (5) who examined the outcomes of pediatric renal
transplants. The former analysis looked at liver transplant
outcomes from 1987 to 1994; 1-year mortality at centers
that performed fewer than 20 transplants per year and
were not affiliated with a high-volume center was 28.3%
compared with 18.2% at centers that performed more than
20 transplants (OR 2.08; 95% confidence interval 1.65–
2.61). However, unlike the current study, there was a sig-
nificant discrepancy between the total number of trans-
plants performed at high- (89%) and low- (11%) volume
centers. In addition, the volume cut-off was determined af-
ter a review of data from the previous 5 years, which may
have enhanced the differences between the two groups
(11). The latter analysis of pediatric renal transplant data
from 1987 to 1995 demonstrated a modest effect of vol-
ume on kidney graft survival. At centers where more than
100 transplants were performed during the study period,
3-month graft survival was 90.4% compared with 90.2%
at centers that performed 50–99 transplants and 88.4% at
centers that performed fewer than 50 transplants. These
authors showed important volume-related differences in
the etiology of graft failure (including graft thrombosis) and
the incidence of acute tubular necrosis. They correlated
these differences with variation in anti-T-cell antibody use
across volume strata.
The volume effects reported in our analysis, while statisti-
cally significant, are modest in comparison with the effect
size reported in studies of widely performed nontransplant
surgical procedures. For example, in studies of the Medi-
care population, high-volume centers were associated with
significantly lower odds of perioperative mortality, ranging
from 12% for carotid endarterectomy to 80% for pancre-
atic resection (1). Several possible explanations may be of-
fered for the modest volume outcome effect size in kidney
and liver transplantation. First, unlike the Medicare analy-
sis, the current analysis used clinical data from the SRTR
rather than relying upon claims data or other administra-
tive data sources. The ability to perform detailed risk ad-
justment using clinical data has been reported to reduce
the measured effect of volume on outcome in other stud-
ies (2). Second, the subset of American hospitals where
transplantation is performed is small and select. In general,
these hospitals must demonstrate skilled anesthesia, radi-
ology, and intensive care capabilities in order to establish a
transplant program (12). Many of the process variables that
contribute to volume differences across a more diverse
group of hospitals performing less scrutinized and regu-
lated surgical procedures may not vary to the same degree
among transplant centers. Third, transplant centers are
subject to a legislatively mandated review process, admin-
istered by a government contractor, which is designed to
ensure high-quality care. Center performance that is signifi-
cantly worse than expected is flagged for audit, review, and
remediation.
This analysis does have several limitations. Despite the
rich set of data available from the SRTR, there are clearly
additional details that may help explain our findings. For
instance, detailed information on the existence of other
potentially important comorbid conditions (e.g. coronary
artery disease) was not available. However, it appears un-
likely that the observed differences are the result of low-
volume centers caring for sicker patients compared with
high-volume centers. In fact, high-volume kidney and liver
transplant centers had higher incidences of older recipi-
ents, patients in the intensive care units, and use of organs
from older donors.
This analysis does not provide evidence of a threshold
that could be used to determine a minimum volume stan-
dard for transplant centers. The study design specifically
avoided the pitfall of post hoc determinations of center vol-
umes associated with better or worse outcome. Rather,
we assigned patients into volume quantiles a priori. This
allowed construction of logistic regression models based
on equal numbers of patients, rather than equal numbers
of centers. The analysis also demonstrates that there is a
large amount of overlap in the range of outcomes across
volume quantiles.
We did not have detailed process variable information (e.g.
operative blood loss) that may have helped to explain bet-
ter outcomes at high-volume centers. Thus, this analy-
sis is limited in its ability to proffer advice on changing
practice at a given center. Also, we did not examine the
potential interaction between center volume and other vari-
ables. Outcome differences may be concentrated primar-
ily in older patients, as has been shown in coronary artery
bypass grafting (13), or among those with previous trans-
plants. However, while these potential interactions may
alter the magnitude of the effect among subgroups, they
are unlikely to alter the fundamental relationships observed
here, as these factors were adjusted for in the multivariate
logistic regression models.
Several potential implications arise from the results of this
study. Currently, efforts are under way to concentrate sur-
gical procedures with significant volume-outcome effects
to large-volume centers (14). The adoption of such a policy
for liver and kidney transplantation would not be straight-
forward even if it were desirable, particularly in the case
of deceased donor transplantation. As with HLA matching,
the benefit of high-volume center performance must be
carefully weighed against the increased risk of graft loss
associated with the increased cold ischemia time which
would likely accompany increased regionalization of trans-
plant services (15). Furthermore, the frequent follow-up
visits necessary after transplantation might prove to be
an added hardship if patients were forced to travel great
distances. Because patients may be more compliant with
follow-up visits if appointments are convenient, compli-
ance may also be an important determinant of outcome.
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The data suggest that there is room for quality improve-
ment. If poor outcome is associated with low-volume, then
low-volume centers with poor outcomes should be offered
assistance in identifying contributing factors. Furthermore,
small centers could be affiliated with larger centers to en-
sure that care plans are maintained at state-of-the-art lev-
els. High-volume centers should be studied in an attempt to
identify best practices associated with superior outcome.
If identified, these patient selection or management strate-
gies could be promulgated to low-volume centers.
In conclusion, outcomes for patients who receive liver or
renal transplants at high-volume centers are better than
those among patients who receive these organs at lower-
volume transplant centers. Future work should examine
process variables that differ between high- and lower-
volume centers and examine the interaction of comorbid
conditions and center volume. Despite potential advan-
tages of regionalization to large-volume centers, caution is
necessary, given the potential adverse effects of increased
cold ischemia time and the implications for post-transplant
monitoring.
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